Long term results of liver transplantation for alpha-1 antitrypsin deficiency - Université de Montpellier
Article Dans Une Revue Digestive and Liver Disease Année : 2021

Long term results of liver transplantation for alpha-1 antitrypsin deficiency

Yasmina Chouik

Résumé

Introduction: Liver transplantation (LT) is the therapeutic option for end-stage liver disease associated with alpha1 antitrypsin (A1AT) deficiency. The aim of the present retrospective study was to report on long-term outcomes following LT for A1AT deficiency.Methods: The medical records of 90 pediatric and adult patients transplanted between 1982 and 2017 in France and Geneva (Switzerland) were reviewed.Results: The study population consisted of 32 adults and 58 children; median age at transplant was 13.0 years (range: 0.2-65.1), and 65 were male (72.2%). Eighty-two patients (94.8% of children and 84.4% of adults) had the PI*ZZ genotype/phenotype and eight patients (8.9%) had the Pi*SZ genotype/phenotype. Eighty-four patients (93.3%) were transplanted for end-stage liver disease and six (all Pi*ZZ adults) for HCC. Median follow-up after LT was 13.6 years (0.1-31.7). The overall cumulative patient survival rates post-transplant were 97.8% at 1 year, and 95.5%, 95.5%, 92.0%, 89.1% at 5, 10, 15, 20 years respectively. The overall cumulative graft survival rates were 92.2% at 1 year, and 89.9%, 89.9%, 84.4%, 81.5% at 5, 10, 15 and 20 years, respectively.Conclusions: In a representative cohort of patients having presented with end-stage-liver disease or HCC secondary to A1AT, liver transplantation offered very good patient and graft survival rates.
Fichier principal
Vignette du fichier
S1590865820309701.pdf (620.57 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03270191 , version 1 (09-05-2023)

Licence

Identifiants

Citer

Olivier Guillaud, Emmanuel Jacquemin, Eduardo Couchonnal, Claire Vanlemmens, Claire Francoz, et al.. Long term results of liver transplantation for alpha-1 antitrypsin deficiency. Digestive and Liver Disease, 2021, 53 (5), pp.606-611. ⟨10.1016/j.dld.2020.10.016⟩. ⟨hal-03270191⟩
79 Consultations
52 Téléchargements

Altmetric

Partager

More